RFID technology for blood tracking: An experimental approach for benchmarking different devices

OBJECTIVE: The objective of the paper is to design a testing protocol to measure performances of RFID devices applied to blood supply chain, and to implement an experimental campaign in order to collect performance data. The protocol matches operational conditions in blood supply chain and is particularly tailored to some critical processes, which can benefit from RFID adoption. The paper thus strives at benchmarking performances of inlays, fixed and handheld RFID readers, when deployed in the blood supply chain processes. DESIGN, METHODOLOGY, APPROACH: The adopted testing protocol enables the assessment of performances of RFID devices in processes of the blood supply chain, since it has been developed peculiarly to emulate critical logistics processes. The testing protocol has been designed jointly with hospital personnel involved in every day operations on blood bags and tubes in order to improve processes, in terms of safety and reliability. The testing protocol has been applied to 3 inlays, 2 fixed readers, 1 mobile handheld in 3 logistics processes, all operating according to UHF EPC class 1 gen 2 protocols and ETSI regulations. We measured and compared read rates, accuracies and read times. FINDINGS: The results of the test give a direct insight of performances to be expected from different RFID devices when deployed in a real-world environment. Therefore, it is possible to give answers to how a specific piece of hardware - such as an inlay or a reader - performs, and how it can be effectively used to improve security of patients in healthcare. At the same time, researchers focusing on the business process reengineering of blood supply chain can assess the technical feasibility of the RFID-reengineered logistics processes in order to improve the safety of end users

Altered cholesterol ester cycle in ex vivo skin fibroblasts from Alzheimer patients

Recent studies in both animal and cell models of Alzheimer's disease (AD) indicated that sub-cellular cholesterol distribution seems to regulate amyloid-beta (A[beta]) generation in the brain. In particular, cholesterol-esters (CE), rather than total cholesterol levels, appear directly correlated with A[beta] production. Here we observed that, similarly to brain cells, skin fibroblasts obtained from AD patients produce and accumulate more CE than skin fibroblasts from age-matched healthy controls do. AD fibroblasts also exhibited a 2 fold increase in the expression of ACAT1, in addition to lower levels of SREBP2, nCEH, Caveolin-1 and ABCA1 mRNA levels, all of which are involved in the CE cycle. HMGCoA-reductase and LDL-receptor mRNAs levels did not show statistically significant changes in AD, compared to non-AD, cells. Furthermore, although APP mRNA did not significantly vary, neprilysin (NEP), the most important enzyme in the proteolysis of A[beta], was expressed at very low levels in skin fibroblasts of sporadic AD patients. Our results contribute to the concept that AD may be the consequence of a basic and systemic defect in the CE cycle. Moreover, our results identify new possible targets for the diagnosis, prevention, and cure or, at least, amelioration of the symptoms of AD

Cabbage and fermented vegetables : From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Large differences in COVID-19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe, or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage have been associated with low death rates in European countries. SARS-CoV-2 binds to its receptor, the angiotensin-converting enzyme 2 (ACE2). As a result of SARS-CoV-2 binding, ACE2 downregulation enhances the angiotensin II receptor type 1 (AT(1)R) axis associated with oxidative stress. This leads to insulin resistance as well as lung and endothelial damage, two severe outcomes of COVID-19. The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is the most potent antioxidant in humans and can block in particular the AT(1)R axis. Cabbage contains precursors of sulforaphane, the most active natural activator of Nrf2. Fermented vegetables contain many lactobacilli, which are also potent Nrf2 activators. Three examples are: kimchi in Korea, westernized foods, and the slum paradox. It is proposed that fermented cabbage is a proof-of-concept of dietary manipulations that may enhance Nrf2-associated antioxidant effects, helpful in mitigating COVID-19 severity.Peer reviewe

Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies

There are large between- and within-country variations in COVID-19 death rates. Some very low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have a common feature of eating large quantities of fermented foods whose intake is associated with the activation of the Nrf2 (Nuclear factor (erythroid-derived 2)-like 2) anti-oxidant transcription factor. There are many Nrf2-interacting nutrients (berberine, curcumin, epigallocatechin gallate, genistein, quercetin, resveratrol, sulforaphane) that all act similarly to reduce insulin resistance, endothelial damage, lung injury and cytokine storm. They also act on the same mechanisms (mTOR: Mammalian target of rapamycin, PPAR gamma:Peroxisome proliferator-activated receptor, NF kappa B: Nuclear factor kappa B, ERK: Extracellular signal-regulated kinases and eIF2 alpha:Elongation initiation factor 2 alpha). They may as a result be important in mitigating the severity of COVID-19, acting through the endoplasmic reticulum stress or ACE-Angiotensin-II-AT(1)R axis (AT(1)R) pathway. Many Nrf2-interacting nutrients are also interacting with TRPA1 and/or TRPV1. Interestingly, geographical areas with very low COVID-19 mortality are those with the lowest prevalence of obesity (Sub-Saharan Africa and Asia). It is tempting to propose that Nrf2-interacting foods and nutrients can re-balance insulin resistance and have a significant effect on COVID-19 severity. It is therefore possible that the intake of these foods may restore an optimal natural balance for the Nrf2 pathway and may be of interest in the mitigation of COVID-19 severity

Performance analysis of a healthcare supply chain for RFID-enabled process reengineering

This study is part of a project which aims to study innovative RFID-based management systems, to optimise logistics in a blood transfusion centre (BTC). In 2009, an analysis of transfusion processes (AS IS 2009) and criticalities was carried out and a RFID-based process reengineering was performed (TO BE 2009). After several technical and management changes in BTC, a further process analysis was carried out and a new model (AS IS 2013) was implemented. The aim of the study is to evaluate efficiency and safety levels of BTC at present, and to compare the models using a coherent methodological approach. A failure modes, effects and criticalities analysis (FMECA) was carried out, in order to highlight criticalities related to patient safety and ad hoc key performance indicators (KPI) were designed and calculated for the two as is models. This paper describes a significant step prior to the design of UHF RFID systems

Safety and logistics performance evaluation of a RFId system in a blood transfusion centre

This papers aims to describe the development framework of a Transfusion Medicine RFId application, which was designed in order to enhance patient safety and in order to improve blood inventory management processes. In the first part of the study, a reverse engineering of present processes (As-Is) was performed through two analysis tools: Flow Charts and Activity Forms. In the second part of the study, an RFId-based processes re-engineering has been designed in order to reduce criticalities and to improve Transfusion Medicine service performance. Then a Return on Safety (ROS) assessment was performed through a RFId-enabled processes FMECA and through Key Performance Indexes (KPI) design. ROS assessment showed a clinical risk reduction in every blood chain process

Technical and economic analysis for the recovery of high biological value products from the cheese-making whey

The residuals of the milk transformation in a dairy industry are the scotta and/or the whey, depending on the production of the ricotta in addition to the cheese. Their disposal represents a technical and economical problem for the dairies due to their high pollutant content. At present, not being possible a direct disposal, such sludge are dried and used for pig nutrition. An alternative use consists in extracting, from these treatment residuals, high added value components, like, for example, lactose and serum proteins. In the present work a technical and economic feasibility study for the realisation of a plant for treating ovine milk serum is performed. The plant is located in Sardinia. Among the different technologies available on the market the one based on a membrane was employed, which allows the recovery and separation of the different components by means of subsequent crossings of different cut-off membranes. Eventually, the plant initial and operating costs were evaluated and the economic analysis of the investment was performed